Gland Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ROCURONIUM BROMIDE USP, with a corresponding US DMF Number 20833.
Remarkably, this DMF maintains an Active status since its submission on September 05, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 10, 2024, and payment made on July 08, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II